| Published Application/Species/Sample/Dilution | Reference |
|---|
- flow cytometry; mouse; 1:50; loading ...; fig s6k
| Xiong W, Gao X, Zhang T, Jiang B, Hu M, Bu X, et al. USP8 inhibition reshapes an inflamed tumor microenvironment that potentiates the immunotherapy. Nat Commun. 2022;13:1700 pubmed publisher |
| Ji Y, Luo Y, Wu Y, Sun Y, Zhao L, Xue Z, et al. SEL1L-HRD1 endoplasmic reticulum-associated degradation controls STING-mediated innate immunity by limiting the size of the activable STING pool. Nat Cell Biol. 2023;25:726-739 pubmed publisher |
| Do Thi V, Park S, Park S, Jeong H, Cho G, An H, et al. IL9 Polarizes Macrophages to M1 and Induces the Infiltration of Antitumor Immune Cells via MIP-1 and CXCR3 Chemokines. Cancer Res Commun. 2023;3:80-96 pubmed publisher |
| Diao L, Ma L, Cheng J, Pan Y, Peng Z, Zhang L, et al. Across-cancer specific immune responses induced by nanovaccines or microvaccines to prevent different cancers and cancer metastasis. iScience. 2022;25:105511 pubmed publisher |
| Stanzione M, Zhong J, Wong E, LaSalle T, Wise J, Simoneau A, et al. Translesion DNA synthesis mediates acquired resistance to olaparib plus temozolomide in small cell lung cancer. Sci Adv. 2022;8:eabn1229 pubmed publisher |
| Wang H, Liu G, Jin X, Song S, Chen S, Zhou P, et al. BET inhibitor JQ1 enhances anti-tumor immunity and synergizes with PD-1 blockade in CRC. J Cancer. 2022;13:2126-2137 pubmed publisher |
| Koikawa K, Kibe S, Suizu F, Sekino N, Kim N, Manz T, et al. Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy. Cell. 2021;184:4753-4771.e27 pubmed publisher |
| Desu H, Illiano P, Choi J, Ascona M, Gao H, Lee J, et al. TNFR2 Signaling Regulates the Immunomodulatory Function of Oligodendrocyte Precursor Cells. Cells. 2021;10: pubmed publisher |
| Li Y, Elmén L, Segota I, Xian Y, Tinoco R, Feng Y, et al. Prebiotic-Induced Anti-tumor Immunity Attenuates Tumor Growth. Cell Rep. 2020;30:1753-1766.e6 pubmed publisher |
| Guo J, Xiao Y, Iyer R, Lu X, Lake M, Ladror U, et al. Empowering therapeutic antibodies with IFN-α for cancer immunotherapy. PLoS ONE. 2019;14:e0219829 pubmed publisher |
| Engelbertsen D, Autio A, Verwilligen R, Depuydt M, Newton G, Rattik S, et al. Increased lymphocyte activation and atherosclerosis in CD47-deficient mice. Sci Rep. 2019;9:10608 pubmed publisher |
| Snell L, Macleod B, Law J, Osokine I, Elsaesser H, Hezaveh K, et al. CD8+ T Cell Priming in Established Chronic Viral Infection Preferentially Directs Differentiation of Memory-like Cells for Sustained Immunity. Immunity. 2018;49:678-694.e5 pubmed publisher |
| Fujita Y, Khateb A, Li Y, Tinoco R, Zhang T, Bar Yoseph H, et al. Regulation of S100A8 Stability by RNF5 in Intestinal Epithelial Cells Determines Intestinal Inflammation and Severity of Colitis. Cell Rep. 2018;24:3296-3311.e6 pubmed publisher |
| Zhou K, Zhu H, Huang L, Guo Y, Yan Y. Induction of anti-tumor immunity by dendritic cells pulsed with an endoplasmic reticulum retrieval signal modifies heparanase epitope in mice. Cytotherapy. 2010;12:735-42 pubmed publisher |
| Tang X, Wan Y, Chen L, Chen T, Yu S, Xiong Z, et al. H-2Kb-restricted CTL epitopes from mouse heparanase elicit an antitumor immune response in vivo. Cancer Res. 2008;68:1529-37 pubmed publisher |
